Form 4: Prestige Consumer Healthcare CEO Lombardi Executes Stock Option and Sells Shares
SEC Form 4 Filing
Prestige Consumer Healthcare's CEO, Ronald M. Lombardi, exercised stock options and sold shares on November 19, 2024, according to a recent SEC filing.
Summary
- Ronald M. Lombardi, CEO of Prestige Consumer Healthcare, engaged in multiple transactions involving the company's stock on November 19, 2024.
- He exercised options to acquire 5,213 shares at $57.18 and 5,662 shares at $56.11.
- Concurrently, he sold 5,213 shares at a weighted average price of $82.55 and 5,662 shares at a weighted average price of $82.64.
- These transactions resulted in a net change in his holdings, with a final total of 320,952 shares directly owned.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing stock transactions by the CEO. It is neither particularly positive nor negative, reflecting standard executive compensation practices.
Risks
- The sale of shares by the CEO could be interpreted negatively by the market, potentially impacting the stock price.
Industry Context
This type of transaction is common for executives who receive stock options as part of their compensation. It is a routine disclosure required by the SEC.
Comparison to Industry Standards
- Executive stock option exercises and sales are a standard practice across publicly traded companies.
- The timing and volume of these transactions are often scrutinized by investors as they can signal management's view of the company's future prospects.
- Comparable companies in the consumer healthcare sector also have executives who regularly exercise and sell stock options.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/08/2017 | Date of power of attorney on file with the Commission. |
| 05/09/2017 | First vesting date for 17,908 shares of stock options. |
| 05/08/2018 | First vesting date for 13,129 shares of stock options. |
| 05/09/2018 | Second vesting date for 17,908 shares of stock options. |
| 05/08/2019 | Second vesting date for 13,129 shares of stock options. |
| 05/09/2019 | Third vesting date for 17,909 shares of stock options. |
| 05/08/2020 | Third vesting date for 13,129 shares of stock options. |
| 05/08/2026 | Expiration date for stock options exercised on 11/19/2024 at $57.18. |
| 05/08/2027 | Expiration date for stock options exercised on 11/19/2024 at $56.11. |
| 11/19/2024 | Date of stock option exercise and share sales. |
| 11/21/2024 | Date of filing of the SEC Form 4. |
Keywords
Prestige Consumer Healthcare, Ronald M. Lombardi, stock options, share sale, SEC Form 4, insider trading, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.